Insufficient scRNA-seq data for expression of ARTN at single-cell level.
Insufficient scRNA-seq data for expression of ARTN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 90% | 133.22 | 162 / 180 | 93% | 7.20 | 401 / 430 |
prostate | 100% | 559.00 | 244 / 245 | 82% | 3.15 | 412 / 502 |
uterus | 100% | 215.11 | 170 / 170 | 78% | 10.69 | 357 / 459 |
bladder | 95% | 147.48 | 20 / 21 | 67% | 6.38 | 339 / 504 |
esophagus | 96% | 170.49 | 1388 / 1445 | 62% | 13.76 | 113 / 183 |
breast | 89% | 116.89 | 408 / 459 | 69% | 6.32 | 767 / 1118 |
lung | 93% | 150.22 | 538 / 578 | 58% | 13.33 | 670 / 1155 |
intestine | 95% | 123.11 | 917 / 966 | 46% | 1.84 | 242 / 527 |
stomach | 94% | 86.74 | 336 / 359 | 37% | 1.63 | 107 / 286 |
pancreas | 98% | 76.58 | 320 / 328 | 30% | 1.32 | 53 / 178 |
thymus | 98% | 99.17 | 641 / 653 | 20% | 0.94 | 123 / 605 |
kidney | 100% | 211.64 | 89 / 89 | 15% | 0.83 | 136 / 901 |
brain | 81% | 94.02 | 2149 / 2642 | 19% | 0.71 | 135 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.89 | 1 / 1 |
blood vessel | 85% | 176.94 | 1134 / 1335 | 0% | 0 | 0 / 0 |
adipose | 82% | 117.42 | 992 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 72% | 48.58 | 186 / 258 | 9% | 0.35 | 21 / 230 |
skin | 68% | 42.24 | 1230 / 1809 | 6% | 0.31 | 27 / 472 |
spleen | 72% | 43.87 | 173 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 9.91 | 31 / 45 |
heart | 61% | 63.56 | 524 / 861 | 0% | 0 | 0 / 0 |
liver | 29% | 14.76 | 65 / 226 | 8% | 0.33 | 31 / 406 |
muscle | 33% | 18.82 | 262 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 15% | 25.46 | 139 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0061146 | Biological process | Peyer's patch morphogenesis |
GO_0097021 | Biological process | lymphocyte migration into lymphoid organs |
GO_0050930 | Biological process | induction of positive chemotaxis |
GO_0007422 | Biological process | peripheral nervous system development |
GO_0007411 | Biological process | axon guidance |
GO_0007405 | Biological process | neuroblast proliferation |
GO_0035860 | Biological process | glial cell-derived neurotrophic factor receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0030116 | Molecular function | glial cell-derived neurotrophic factor receptor binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0008083 | Molecular function | growth factor activity |
Gene name | ARTN |
Protein name | Artemin (Enovin) (Neublastin) Artemin |
Synonyms | EVN |
Description | FUNCTION: Ligand for the GFR-alpha-3-RET receptor complex but can also activate the GFR-alpha-1-RET receptor complex. Supports the survival of sensory and sympathetic peripheral neurons in culture and also supports the survival of dopaminergic neurons of the ventral mid-brain. Strong attractant of gut hematopoietic cells thus promoting the formation Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. . |
Accessions | ENST00000498139.6 [Q5T4W7-3] ENST00000372354.3 [Q5T4W7-1] ENST00000372359.10 [Q5T4W7-1] ENST00000414809.7 [Q5T4W7-3] ENST00000479128.5 ENST00000438616.3 [Q5T4W7-2] ENST00000474592.1 E9PIK2 E9PN22 ENST00000472435.1 ENST00000491846.5 E9PLG3 ENST00000477048.5 Q5T4W7 ENST00000471394.6 |